PTSM: Pharmaceutical Technology Sourcing and Management
Pfizer announced the launch of Pfizer CentreOne, a CMO formed by the combination of Pfizer CentreSource and Hospira One 2 One.
Pfizer’s newly combined global CMO, Pfizer CentreOne, launched on April 20, 2016. The CMO will focus specifically on API synthesis and sterile injectables fill-finish, Pfizer said in a press announcement.
Pfizer CentreOne was formed by the combination of Pfizer CentreSource and Hospira One 2 One. The formation comes after Pfizer acquired One 2 One in September 2015. The newly formed CMO plans to combine Pfizer’s knowledge of specialty APIs with One 2 One’s work with sterile injectables.
Pfizer CentreOne’s core offerings will include:
“As a combined organization, we’ve brought together the best of our manufacturing capabilities to provide a wider array of services and technologies to our biopharmaceutical partners,” said Peter Stevenson, vice-president and general manager of Pfizer CentreOne, in a press announcement. “Although Pfizer CentreOne is a new name, we’ve been providing contract manufacturing services for more than 40 years and are committed to further growing our business.”
Source: Pfizer
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.